Alexandra Dietrich

Director Ejecutivo en Syntacoll Gmbh .

Consumer Services

Health Technology

Perfil

Alexandra Dietrich is currently the Managing Director at Syntacoll GmbH since 2007.
She holds a doctorate degree from Ludwig-Maximilians-Universität München.

Cargos activos de Alexandra Dietrich

Empresas	Cargo	Inicio
Syntacoll Gmbh Syntacoll Gmbh Pharmaceuticals: MajorHealth Technology Part of Innocoll Holdings Plc, Syntacoll GmbH is a German pharmaceutical company that develops and manufactures fully resorbable collagen-based implants. The company is based in Saal an der Donau, Germany and was founded in 1992. The CEOs are Alexandra Dietrich and Kimball Hall. Syntacoll is the only development and production site of Innocoll, and their products are manufactured according to GMP and ISO 13485 standards. The company holds a manufacturing license for active substance-containing drugs based on collagen. Syntacoll's mission is to provide innovative medical and pharmaceutical products for patient care, and their vision is to be recognized as one of the leading providers of medical and pharmaceutical products worldwide. The company values integrity, inclusion, collaboration, and responsibility.	Director Ejecutivo	01/03/2007

Todos los cargos activos de Alexandra Dietrich

Formación de Alexandra Dietrich.

Ludwig-Maximilians-Universität München

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Alexandra Dietrich.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Syntacoll Gmbh Syntacoll Gmbh Pharmaceuticals: MajorHealth Technology Part of Innocoll Holdings Plc, Syntacoll GmbH is a German pharmaceutical company that develops and manufactures fully resorbable collagen-based implants. The company is based in Saal an der Donau, Germany and was founded in 1992. The CEOs are Alexandra Dietrich and Kimball Hall. Syntacoll is the only development and production site of Innocoll, and their products are manufactured according to GMP and ISO 13485 standards. The company holds a manufacturing license for active substance-containing drugs based on collagen. Syntacoll's mission is to provide innovative medical and pharmaceutical products for patient care, and their vision is to be recognized as one of the leading providers of medical and pharmaceutical products worldwide. The company values integrity, inclusion, collaboration, and responsibility.	Health Technology